BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 28560499)

  • 1. The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States.
    Zhang Y; Wilson TE; Adedimeji A; Merenstein D; Milam J; Cohen J; Cohen M; Golub ET
    AIDS Behav; 2018 Mar; 22(3):896-908. PubMed ID: 28560499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicinal and recreational marijuana use among HIV-infected women in the Women's Interagency HIV Study (WIHS) cohort, 1994-2010.
    Dʼsouza G; Matson PA; Grady CD; Nahvi S; Merenstein D; Weber KM; Greenblatt R; Burian P; Wilson TE
    J Acquir Immune Defic Syndr; 2012 Dec; 61(5):618-26. PubMed ID: 23011399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance Use Stigma and Antiretroviral Therapy Adherence Among a Drug-Using Population Living with HIV.
    Stringer KL; Marotta P; Baker E; Turan B; Kempf MC; Drentea P; Stepanikova I; Turan JM
    AIDS Patient Care STDS; 2019 Jun; 33(6):282-293. PubMed ID: 31166784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-intensity cannabis use and adherence to antiretroviral therapy among people who use illicit drugs in a Canadian setting.
    Slawson G; Milloy MJ; Balneaves L; Simo A; Guillemi S; Hogg R; Montaner J; Wood E; Kerr T
    AIDS Behav; 2015 Jan; 19(1):120-7. PubMed ID: 25012624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining adherence barriers among women with HIV to tailor outreach for long-acting injectable antiretroviral therapy.
    Benning L; Mantsios A; Kerrigan D; Coleman JS; Golub E; Blackstock O; Konkle-Parker D; Philbin M; Sheth A; Adimora AA; Cohen MH; Seidman D; Milam J; Kassaye SG; Taylor T; Murray M
    BMC Womens Health; 2020 Jul; 20(1):152. PubMed ID: 32711509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in single-tablet regimen use and associated improvements in adherence-related outcomes in HIV-infected women.
    Hanna DB; Hessol NA; Golub ET; Cocohoba JM; Cohen MH; Levine AM; Wilson TE; Young M; Anastos K; Kaplan RC
    J Acquir Immune Defic Syndr; 2014 Apr; 65(5):587-96. PubMed ID: 24326606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receipt of opioid agonist treatment halves the risk of HIV-1 RNA viral load rebound through improved ART adherence for HIV-infected women who use illicit drugs.
    Adams JW; Marshall BDL; Mohd Salleh NA; Barrios R; Nolan S; Milloy MJ
    Drug Alcohol Depend; 2020 Jan; 206():107670. PubMed ID: 31711873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting.
    Joseph B; Kerr T; Puskas CM; Montaner J; Wood E; Milloy MJ
    AIDS Care; 2015; 27(9):1128-36. PubMed ID: 25915438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Nonlipid Cardiovascular Disease Risk Factor Management in the Women's Interagency HIV Study and Association with Adherence to Antiretroviral Therapy.
    Hanna DB; Jung M; Xue X; Anastos K; Cocohoba JM; Cohen MH; Golub ET; Hessol NA; Levine AM; Wilson TE; Young MA; Kaplan RC
    AIDS Patient Care STDS; 2016 Oct; 30(10):445-454. PubMed ID: 27749112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Material security and adherence to antiretroviral therapy among HIV-positive people who use illicit drugs.
    Mohd Salleh NA; Van Draanen J; Nosova E; Barrios R; Milloy MJ; Richardson L
    AIDS; 2020 Jun; 34(7):1037-1045. PubMed ID: 32073444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal patterns of illicit drug use, antiretroviral therapy exposure and plasma HIV-1 RNA viral load among HIV-positive people who use illicit drugs.
    Liang J; Nosova E; Reddon H; Nolan S; Socías E; Barrios R; Milloy MJ
    AIDS; 2020 Jul; 34(9):1389-1396. PubMed ID: 32590435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship Between Single Tablet Antiretroviral Regimen and Adherence to Antiretroviral and Non-Antiretroviral Medications Among Veterans' Affairs Patients with Human Immunodeficiency Virus.
    Yager J; Faragon J; McGuey L; Hoye-Simek A; Hecox Z; Sullivan S; Neubert S; Patel N
    AIDS Patient Care STDS; 2017 Sep; 31(9):370-376. PubMed ID: 28771023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Longitudinal Analysis of Daily Pill Burden and Likelihood of Optimal Adherence to Antiretroviral Therapy Among People Living With HIV Who Use Drugs.
    Mohd Salleh NA; Richardson L; Kerr T; Shoveller J; Montaner J; Kamarulzaman A; Milloy MJ
    J Addict Med; 2018; 12(4):308-314. PubMed ID: 29521670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-persistence to antiretroviral therapy among adults receiving HIV medical care in the United States.
    Nyaku M; Beer L; Shu F
    AIDS Care; 2019 May; 31(5):599-608. PubMed ID: 30309269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Menstrual cycle phase and single tablet antiretroviral medication adherence in women with HIV.
    Hessol NA; Holman S; Minkoff H; Cohen MH; Golub ET; Kassaye S; Karim R; Sosanya O; Shaheen C; Merhi Z
    AIDS Care; 2016; 28(1):11-21. PubMed ID: 26274806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms for the Negative Effects of Internalized HIV-Related Stigma on Antiretroviral Therapy Adherence in Women: The Mediating Roles of Social Isolation and Depression.
    Turan B; Smith W; Cohen MH; Wilson TE; Adimora AA; Merenstein D; Adedimeji A; Wentz EL; Foster AG; Metsch L; Tien PC; Weiser SD; Turan JM
    J Acquir Immune Defic Syndr; 2016 Jun; 72(2):198-205. PubMed ID: 26885803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syndemic factors associated with adherence to antiretroviral therapy among HIV-positive adult heterosexual men.
    McMahon JM; Braksmajer A; Zhang C; Leblanc N; Chen M; Aidala A; Simmons J
    AIDS Res Ther; 2019 Nov; 16(1):32. PubMed ID: 31706357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug use and antiretroviral therapy (ART) interactions: a qualitative study to explore the knowledge, beliefs, adherence, and quality of life of people living with HIV taking ART and illicit drugs.
    Fuster-RuizdeApodaca MJ; Castro-Granell V; Laguía A; Jaén Á; Cenoz S; Galindo MJ
    AIDS Res Ther; 2020 May; 17(1):24. PubMed ID: 32448214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms.
    Bonn-Miller MO; Oser ML; Bucossi MM; Trafton JA
    J Behav Med; 2014 Feb; 37(1):1-10. PubMed ID: 23054178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of race, substance abuse, and health insurance coverage with use of highly active antiretroviral therapy among HIV-infected women, 2005.
    Lillie-Blanton M; Stone VE; Snow Jones A; Levi J; Golub ET; Cohen MH; Hessol NA; Wilson TE
    Am J Public Health; 2010 Aug; 100(8):1493-9. PubMed ID: 19910347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.